3 New Strong Buy Ratings from Top-Rated Analysts: 04/10/2025

By Mijuško Šibalić, Stock Market Writer and Stock Researcher
April 10, 2025 5:58 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 04/10/2025

Even in a decidedly ugly market, analysts remain bullish on select stocks. We sourced these from our Strong Buy Stocks from Top Wall Street Analysts screener:

  • Vertiv Holdings Co. (NYSE: VRT) offers a unique way to break into AI investing 
  • With a long list of heavyweight clients, Braze Inc. (NASDAQ: BRZE) is a top pick among analysts 
  • McKesson Corp. (NYSE: MCK) reigns supreme in a trending industry

P.S. Want more alerts like this daily? Try WallStreetZen Premium.

1. Braze Inc. (NASDAQ: BRZE)

This cloud-based customer engagement platform’s client list is a roll call of heavyweights, including Burger King, NASCAR, and Venmo. There’s a real appetite for customer retention — and the business is well-positioned to capture that demand, particularly as it has just completed a key acquisition.

Zen Rating: B (Buy)see full analysis >  

Recent Price: $30.98  — get current quote > 

Max 1-year forecast: $68.00 

Why we’re watching:

  • At present, 14 analysts issue ratings for BRZE stock. A majority of them — 9, to be exact, have given the stock a Strong Buy rating, with the remaining ratings split between 4 Buys and a single Hold. See the ratings
  • On March 28, following the company’s Q4 and FY 2025 earnings, Citigroup’s Tyler Radke (a top 18% rated analyst) reiterated a Strong Buy rating, and increased his price target from $50 to $55.
  • The company "delivered a strong finish to FY 2025" and issued better-than-expected FY 2026 organic growth guidance of 16%, excluding the impact of the OfferFit acquisition, Radke told readers.
  • The analyst said they "believe there is healthy room for upside to management's guidance" from the purchase of OfferFit, a startup with an AI decisioning engine, whose sales tripled last year.
  • Braze Inc stock has an overall Zen Rating of B — and stocks with that distinction have outperformed the market on a consistent basis over the course of the past two and a half decades.
  • Two things stand out when it comes to BRZE’s Component Grade ratings. When it comes to Growth, it ranks in the top 4%. As impressive as that is, the stock’s Sentiment rating is the primary appeal — in this category, BRZE ranks in the top 1%. (See all 7 Zen Component Grades here >)

2. McKesson Corp. (NYSE: MCK

This is one of the largest healthcare businesses in the U.S. — a supplier of branded, generic, and specialty pharmaceuticals, as well as medical equipment. Beyond being a solid defensive pick due to the sector it operates in, the company is also on a roll, having provided three consecutive earnings beats and completed a key acquisition last week that could unlock an additional avenue for growth.

 

Zen Rating: B (Buy)see full analysis >  

Recent Price: $630.63   — get current quote > 

Max 1-year forecast: $745.00 

Why we’re watching:

  • A total of 7 analysts track MCK stock — 3 have deemed it a Strong Buy, while 2 analysts gave it a Buy rating. Lastly, the stock also has 2 Hold ratings. See the ratings
  • McKesson Corp stock ranks as the 2nd overall in the Medical Distribution industry.
  • Erin Wright of Morgan Stanley (a top 4% rated analyst) maintained a Strong Buy rating on MCK shares on April 2. The researcher also hiked her price target from $642 to a Street-high $745.
  • In an overview note, Wright contextualized their price target hike on McKesson by saying that "drug distributors have re-rated higher and have held relatively steady in volatility."
  • Looking ahead, the analyst said that this should continue given the group's "robust fundamental backdrop”.
  • Noting that McKesson management typically excludes MCK Venture contributions from long-term guidance, Wright told investors to expect FY 2026 EPS growth to slightly exceed the high end of the company's 12% to 14% long-term range, excluding the impact of MCK Ventures.
  • On April 2, the business completed its acquisition of PRISM Vision Holdings for $850 million, significantly expanding its ophthalmology footprint.
  • McKesson Corp shares rank in the top 16% of equities, earning them an overall Zen Rating of B, which corresponds to an average annual return of 19.88%.
  • Perhaps even more enticing, considering current market conditions, MCK ranks quite highly in terms of Safety — in the 82nd percentile. Moreover, McKesson Corp shares rank in the top 7% of equities when it comes to Growth.
  • (See all 7 Zen Component Grades here >)

3. Vertiv Holdings Co. (NYSE: VRT)

VRT stock offers a unique way to gain exposure to artificial intelligence — the company does everything from installation and maintenance to repair when it comes to data centers. On top of that, it is one of the leading power management and, more importantly, cooling providers in the industry. With an already strong tailwind from Project Stargate, as well as record-breaking AI CAPEX, the business is well-positioned to capture a lot of growth from a dynamic narrative.

Zen Rating: A (Strong Buy)see full analysis >  

Recent Price: $59.22get current quote > 

Max 1-year forecast: $155.00 

Why we’re watching:

  • At present, Vertiv Holdings has 8 Strong Buy ratings, 4 Buy ratings, and 2 Hold ratings. See the ratings
  • RBC Capital’s Deane Dray (a top 9% rated analyst) initiated coverage on VRT stock recently, and set a 12-month price forecast of $121, equating to a 79.34% upside.
  • Because 80% of its revenue is from data centers, Dray characterized Vertiv Holdings as a near-pureplay data center power/thermal solutions provider with "scarcity value" as well as an array of number one to number three market positions, including top-two in liquid cooling.
  • Being on coveted hyperscaler "approved vendor lists" is also a meaningful barrier to entry that favors the name, the analyst added.
  • Vertiv Holdings stock carries an overall Zen Rating of A, and ranks in the 97th percentile of stocks overall.
  • It’s impossible to overstate the growth potential that being a key data center infrastructure provider carries — but perhaps we can paint a picture with VRT’s Growth Component Grade rating, which puts it in the top 4% of equities in that regard. (See all 7 Zen Component Grades here >)

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.